Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Trading under Its 20 Day MA ($6.88), Why Showing An Interesting Price Pattern?
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) does about 5.69M shares in volume on a normal day but saw 3007213 shares change hands in the recent trading day. The company now has a market cap of 1.88B USD. Its current market price is $6.65, marking an increase of 1.22% compared to the previous close of $6.57. The 52 […]
Are Analysts Too Bullish On Recursion Pharmaceuticals Inc (RXRX)
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) currently has a daily average trading volume of 5.72M but it saw 3440905 shares traded in last market. With a market cap of 1.83B USD, the company’s current market price of $6.50 came rising about 0.78 while comparing to the previous closing price of $6.45. In past 52 weeks, the stock […]
Recursion Pharmaceuticals Inc (RXRX): The Latest Casualty Of Increased Volatility?
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) does about 5.72M shares in volume on a normal day but saw 3903269 shares change hands in the recent trading day. The company now has a market cap of 1.73B USD. Its current market price is $6.12, marking an increase of 3.38% compared to the previous close of $5.92. The 52 […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Emerges As Guiding Light For Investors
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) currently has a daily average trading volume of 5.68M but it saw 5704878 shares traded in last market. With a market cap of 1.72B USD, the company’s current market price of $6.10 came rising about 0.49 while comparing to the previous closing price of $6.07. In past 52 weeks, the stock […]
Recursion Pharmaceuticals Inc (RXRX) Reports -53.75% Fall From For 52 Week High, It’s Always Darkest Before The Dawn
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) does about 5.56M shares in volume on a normal day but saw 3550212 shares change hands in the recent trading day. The company now has a market cap of 2.05B USD. Its current market price is $7.28, marking a decrease of -1.75% compared to the previous close of $7.41. The 52 […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX): Retirees Don’t Worry About Volatility
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) currently has a daily average trading volume of 5.61M but it saw 3595643 shares traded in last market. With a market cap of 2.08B USD, the company’s current market price of $7.37 came falling about -3.15 while comparing to the previous closing price of $7.61. In past 52 weeks, the stock […]
Analyzing Stock On Your Own: Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) does about 5.63M shares in volume on a normal day but saw 3778020 shares change hands in the recent trading day. The company now has a market cap of 2.23B USD. Its current market price is $7.89, marking an increase of 1.02% compared to the previous close of $7.81. The 52 […]
Recursion Pharmaceuticals Inc (RXRX): Investing In A Time Of Crisis
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) currently has a daily average trading volume of 5.61M but it saw 5205740 shares traded in last market. With a market cap of 2.07B USD, the company’s current market price of $7.35 came falling about -3.54 while comparing to the previous closing price of $7.62. In past 52 weeks, the stock […]
Recursion Pharmaceuticals Inc (RXRX): The Latest Casualty Of Increased Volatility?
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) does about 5.57M shares in volume on a normal day but saw 4897907 shares change hands in the recent trading day. The company now has a market cap of 2.02B USD. Its current market price is $7.15, marking an increase of 6.08% compared to the previous close of $6.74. The 52 […]
Ideas And Forecasts On Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) currently has a daily average trading volume of 5.60M but it saw 4981745 shares traded in last market. With a market cap of 1.89B USD, the company’s current market price of $6.69 came rising about 6.53 while comparing to the previous closing price of $6.28. In past 52 weeks, the stock […]
